world allergy congress 2022, istanbul, İstanbul, Turkey, 13 October 2022
Background And Objective: Increased risk of invasive pneumococcal disease (IPD) was reported in children with
asthma before introduction of pneumococcal vaccines (PV), however the evidence is limited after PV entered
routine immunization schedule. We aimed to investigate whether pediatric allergists (PA) recommend additional
PV (aPV) to asthmatic children and if so are there any asthma specific risk factors they consider. We also wanted
to determine any changes in their recommendations during COVID-19 pandemic.
Materials-Methods: An online filled questionnaire consisting of 14 questions (demographic:5, IPD and asthma:
2, aPV:3, COVID-19: 4) was e-mailed to all members of Academy of Pediatric Allergy and Asthma in Türkiye.
Results: The questionnaire was e-mailed to 220 members. The response rate was 56.3% and 60.5% of PA
recommended aPV. The most frequent asthma specific factors for aPV were severe asthma (70.2%), long term oral
corticosteroid use (65.3%) and frequent exacerbations / hospitalizations (62.9%). COVID-19 pandemic increased
the rate of questions asked to PA about aPV for asthmatic children compared to previous periods (75.8 vs 33.9%)
(p<0.001) and %27 of PA changed their recommendations in favor of aPV during pandemic.
Conclusions: Recommendation of aPV by PA for asthmatic children is not infrequent. Severe asthma and related
factors seem to be the leading reasons to recommend aPV for asthmatic children. The aPV recommendation by
PA is increased during COVID-19 pandemic